Global Developmental Delay (GDD) 

Like many other aspects of medicine, the terminology used to describe deviations from the expected development course is contentious. Some believe that "developmental disability" rather than "developmental delay" is the more accurate phrase. Regardless of the preferred language, it is currently classified as a developmental delay by financial assistance organisations such as the National Disability Insurance Service (NDIS). 

GDD, which is characterised as a performance >2 standard deviations behind the mean, is a considerable delay observed across many domains of function and adaptation. This delay could signify a delay in achieving or creating accomplished but qualitatively distinct milestones. 

Not all GDD patients will meet the standards for intellectual disability. 

How frequent is it? 

The prevalence of GDD in children under five is thought to be between one and three per cent. 

What triggers it? 

How much string is there? Even while determining the cause may not change how the kid is treated medically, it frequently offers the family several benefits, such as: 

-Providing information about the diagnosis and outlook 

-Acceptable genetic counselling should be allowed for risk of recurrence (and risk for other family members). 

-Limiting future experiments 

-by giving family "answers" and possibly deleting (although this could also make things worse!) guilt 

-recognising risk factors for secondary impairment that may be avoidable may reduce co-morbidity. 

-monitoring of other systems, such as hearing and vision 

-Permit greater support to be accessed via specialised syndrome support groups. 

-Possibility of condition-specific therapy 

Get treatment for global developmental delay from Tomatis® professionals.